Lensar, Inc. revenue by segment LNSR

Annual Quarterly

Lensar, Inc. splits its revenue into 2 lines in its filings. The largest line in fiscal 2025, which ended Dec 31, 2025 was Product at $45.9 million, 89% of the total.

USD in millions. The percent under a figure is the change from the year before.

FY 2026
Jun 30, 2026
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
Revenue
54
52
46
36
29
29
23
Product
47
+2.8%
share 88.2%
46
+11.8%
share 88.9%
41
+29.8%
share 89.3%
32
+21.9%
share 88.6%
26
-1.1%
share 88.2%
26
+32.3%
share 89.0%
20
share 87.1%
Services
6
+20.2%
share 11.8%
6
+17.0%
share 11.1%
5
+20.2%
share 10.7%
4
+16.9%
share 11.4%
3
+7.3%
share 11.8%
3
+10.1%
share 11.0%
3
share 12.9%
How these figures are calculated

Annual columns are full-year amounts from the annual report (Form 10-K, 20-F, or 40-F). If a company restates a year, the latest filed number is shown. USD in millions. Each group is a separate split of total revenue, so the groups are not added together. Share of revenue is that line divided by total revenue. The first column adds the latest year-to-date segment amount to the last fiscal year and subtracts the year-ago year-to-date amount. More on our methodology.

Company profile

Industry
Surgical & Medical Instruments & Apparatus (SIC 3841)
Listed as
LNSR (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Orlando, FL
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1320350
Former names
LensAR Inc (until Jan 14, 2015); LaserSoft Vision Inc (until Jun 16, 2006)

Other Surgical & Medical Instruments & Apparatus companies

All 151 Surgical & Medical Instruments & Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.